These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16618113)

  • 1. Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.
    Polgar O; Ozvegy-Laczka C; Robey RW; Morisaki K; Okada M; Tamaki A; Koblos G; Elkind NB; Ward Y; Dean M; Sarkadi B; Bates SE
    Biochemistry; 2006 Apr; 45(16):5251-60. PubMed ID: 16618113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2.
    Polgar O; Ierano C; Tamaki A; Stanley B; Ward Y; Xia D; Tarasova N; Robey RW; Bates SE
    Biochemistry; 2010 Mar; 49(10):2235-45. PubMed ID: 20088606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.
    Hou YX; Li CZ; Palaniyandi K; Magtibay PM; Homolya L; Sarkadi B; Chang XB
    Biochemistry; 2009 Sep; 48(38):9122-31. PubMed ID: 19691360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2.
    Nakagawa H; Wakabayashi-Nakao K; Tamura A; Toyoda Y; Koshiba S; Ishikawa T
    FEBS J; 2009 Dec; 276(24):7237-52. PubMed ID: 19909340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
    Ozvegy C; Váradi A; Sarkadi B
    J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.
    Diop NK; Hrycyna CA
    Biochemistry; 2005 Apr; 44(14):5420-9. PubMed ID: 15807535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.
    Henriksen U; Fog JU; Litman T; Gether U
    J Biol Chem; 2005 Nov; 280(44):36926-34. PubMed ID: 16107343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.
    Ni Z; Bikadi Z; Cai X; Rosenberg MF; Mao Q
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C1100-9. PubMed ID: 20739628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.
    Litman T; Jensen U; Hansen A; Covitz KM; Zhan Z; Fetsch P; Abati A; Hansen PR; Horn T; Skovsgaard T; Bates SE
    Biochim Biophys Acta; 2002 Sep; 1565(1):6-16. PubMed ID: 12225847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine 383 is a crucial residue in ABCG2 biogenesis.
    Polgar O; Ediriwickrema LS; Robey RW; Sharma A; Hegde RS; Li Y; Xia D; Ward Y; Dean M; Ozvegy-Laczka C; Sarkadi B; Bates SE
    Biochim Biophys Acta; 2009 Jul; 1788(7):1434-43. PubMed ID: 19406100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.
    Ni Z; Bikadi Z; Shuster DL; Zhao C; Rosenberg MF; Mao Q
    Biochemistry; 2011 Sep; 50(37):8057-66. PubMed ID: 21854076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers.
    Bhatia A; Schäfer HJ; Hrycyna CA
    Biochemistry; 2005 Aug; 44(32):10893-904. PubMed ID: 16086592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.
    Macalou S; Robey RW; Jabor Gozzi G; Shukla S; Grosjean I; Hegedus T; Ambudkar SV; Bates SE; Di Pietro A
    Cell Mol Life Sci; 2016 May; 73(9):1927-37. PubMed ID: 26708291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.
    Telbisz Á; Hegedüs C; Váradi A; Sarkadi B; Özvegy-Laczka C
    Drug Metab Dispos; 2014 Apr; 42(4):575-85. PubMed ID: 24384916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system.
    Wakabayashi K; Nakagawa H; Adachi T; Kii I; Kobatake E; Kudo A; Ishikawa T
    J Exp Ther Oncol; 2006; 5(3):205-22. PubMed ID: 16528971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
    Henriksen U; Gether U; Litman T
    J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
    Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.
    Tamura A; Wakabayashi K; Onishi Y; Takeda M; Ikegami Y; Sawada S; Tsuji M; Matsuda Y; Ishikawa T
    Cancer Sci; 2007 Feb; 98(2):231-9. PubMed ID: 17297656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
    Han B; Zhang JT
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):31-42. PubMed ID: 14754410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of ABCG2: role of the GXXXG motif.
    Polgar O; Robey RW; Morisaki K; Dean M; Michejda C; Sauna ZE; Ambudkar SV; Tarasova N; Bates SE
    Biochemistry; 2004 Jul; 43(29):9448-56. PubMed ID: 15260487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.